Paul Kempe
City & Provincial Properties Plc
Kerry Kennedy
RFK / Robert F. Kennedy Human Rights

Brendan Kennedy

President & CEO

Tilray

Seattle, WA, USA

Brendan Kennedy

Biography

Brendan Kennedy is Chief Executive Officer of Tilray, a global leader in medical cannabis industry. Tilray was the first GMP-certified medical cannabis producer to supply products to patients, researchers, and the medical community, earning itself the recognition of being a pioneer in cannabis research, cultivation, processing, and distribution

In 2011, along with Michael Blue and Christian Groh, Brendan Co-founded Privateer Holdings, the world’s first private equity firm to invest exclusively in legal cannabis. At Privateer, Brendan used his background of entrepreneurship and hands-on business experience to successfully lead the development of new and existing companies, origination and distribution of products, and management of operations. While he was at the helm of Privateer, the firm raised over $200 million to build a global portfolio of leading cannabis businesses.

Brendan has always had a voracious appetite for information and keen insight into technology and growth industries, both of which led him to the forefront of consultation and solutions for the venture-backed business community. Prior to co-founding Privateer, he
served as the Chief Operating Officer of Silicon Valley Bank Analytics from 2010 to 2011 and Managing Director from 2006 to 2010. In these roles, he managed an international team that rendered valuation opinions for emerging growth technology, life science and venture capital companies.

Brendan earned a BA from the University of California, Berkeley, an MS in Engineering from the University of Washington, and an MBA from the Yale School of Management.

Brendan Kennedy’s Newsfeed

Market Watch
Tilray says coronavirus has not dented operations

International medical cannabis sales exceed those in Canada, CEO says cannabis revenue has picked up amid global pandemic. In a statement, Chief Executive Brendan Kennedy said ... the company took several steps to make its business more efficient, which should save it $40 million a year, though the measures were not “fully reflected” in the first quarter’s results. The company sold $5.8 million worth of medical weed abroad, which was higher than medical sales in Canada for the first time. “International medical will never go back,” Kennedy said in the earnings call. “It will always be in excess of our Canadian medical revenue.”

MoneyWeek
Brendan Kennedy: the data geek taking cannibis mainstream

Brendan Kennedy was an early mover in the market as the world started to legalise cannabis. It seemed like a crazy and risky decision a decade ago. Now, he's sitting on a fortune, Jane Lewis reports. When Brendan Kennedy gave up his job in finance to gamble on the commercial potential of legal cannabis, everyone thought he was crazy. Nine years on, he has become "a poster child of the green rush", says The Times. He presides over Tilray, a self-described "global leader in cannabis research, cultivation, processing and distribution", which has ridden "an extraordinary global surge towards legalisation".

View allHide

Brendan Kennedy’s Background

President & CEO
Aug 2013 - Present
Nanaimo, CA
Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. It is the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.
Executive Chairman
Jul 2018 - Dec 2020
Seattle, WA, USA
Privateer Holdings is a private equity firm that is actively shaping the remarkably promising cannabis marketplace through the development of strategic acquisitions and investments. Through a combination of acquisitions, investments, and incubation, Privateer is focused on building a portfolio of global brands that will lead, legitimize, and define the future of cannabis.
View allHide

Current Board Positions

Board of Directors
Jan 2018 - Present
Nanaimo, CA
Tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. It is the only GMP certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.

Previous Board Positions

Board of Directors
2011 - 2019
Seattle, WA, USA
Privateer Holdings is a private equity firm that is actively shaping the remarkably promising cannabis marketplace through the development of strategic acquisitions and investments. Through a combination of acquisitions, investments, and incubation, Privateer is focused on building a portfolio of global brands that will lead, legitimize, and define the future of cannabis.

Media

"A CEO Tries to Navigate the Legal Cannabis Sector’s Bad Trip"
Mar 2020
New York, NY, USA
Brendan Kennedy, CEO of Privateer Holdings, Inc. and CEO of Tilray, talks with Chris Kornelis about the burgeoning legal marijuana industry and the opportunities and challenges it poses.
Interview
New York, NY, USA
Tilray CEO Brendan Kennedy joins CNBC’s “Power Lunch” team to discuss the new leadership changes, the outlook for the cannabis industry, and more.
View allHide

Brendan Kennedy’s Education

MS Engineering
1994 - 1995
View allHide